September 2025
1. CHEN W, Baldoni PL, Zhou AX
   From Splicing Landscape to Therapeutic Targets: Long-Read Sequencing in Non-Small-Cell Lung Cancer.
   Am J Respir Cell Mol Biol. 2025 Sep 25. doi: 10.1165/rcmb.2025-0483.
   

   >> Share

   
   June 2025
2. EVANS JF, Ledwell OA, Tang Y, Rue R, et al
   The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in Lymphangioleiomyomatosis.
   Am J Respir Cell Mol Biol. 2025;72:643-652.
   

   >> Share

   
   May 2025
3. TREFIER A, Tousson-Abouelazm N, Yamani L, Ibrahim S, et al
   Enhanced Galphaq Signaling in TSC2-Deficient Cells Is Required for Their Neoplastic Behavior.
   Am J Respir Cell Mol Biol. 2025;72:578-590.
   

   >> Share

   
   November 2024
4. AMOSU MM, Jankowski AM, McCright JC, Yang BE, et al
   Plasmacytoid Dendritic Cells Mediate CpG-ODN-induced Increase in Survival in a Mouse Model of Lymphangioleiomyomatosis.
   Am J Respir Cell Mol Biol. 2024;71:519-533.
   

   >> Share

   
   July 2024
5. XU Y, Li M, Bai L
   Pulmonary Epithelium Cell Fate Determination: COPD, Lung Cancer, or Both.
   Am J Respir Cell Mol Biol. 2024 Jul 30. doi: 10.1165/rcmb.2023-0448.
   

   >> Share

   
   February 2024
6. ROSSI RL, Elia D, Torre O, Cassandro R, et al
   Identification of Lymphangioleiomyomatosis-associated Serum MicroRNAs.
   Am J Respir Cell Mol Biol. 2024;70:146-148.
   

   >> Share

   
   January 2024
7. POWELL RM, Moravec JC, Jones GT, Bhat B, et al
   DNA Methylation Profiling of Heterogeneous Sporadic LAM and Matched Lung Tissue.
   Am J Respir Cell Mol Biol. 2024;70:81-84.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share